Atlas Trials

Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer

Clinical trial NCT00006812 · TERMINATED

Trial details

NCT number
NCT00006812
Sponsor
Gynecologic Oncology Group
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian CancerPrimary Peritoneal Cavity Cancer
Start date
2001-03-01
Primary completion
2005-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.